RT Book, Section
A1 Dolan, Brigid
A1 Walsh, Judith
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1193123124
T1 Cardiovascular Disease Prevention in Women
T2 Current Medical Diagnosis & Treatment 2023
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264687343
LK accessmedicine.mhmedical.com/content.aspx?aid=1193123124
RD 2024/10/11
AB CVD  is  the  leading  cause  of  death  in  women.  Women's  heart  disease  risk  tends  to  lag  about  10  years  behind  that  of  men;  thus,  at  any  given  age,  a  woman's  baseline  risk  will  be  lower  than  that  of  a  man's  baseline  risk.  While  some  heart  disease  risk  factors  such  as  age  and  family  history  are  not  modifiable,  other  risk  factors  such  as  hypertension,  hyperlipidemia,  smoking,  obesity,  and  diabetes  are  potentially  modifiable.  Additionally,  sex-specific  risk  factors  may  impact  a  woman's  risk  of  future  heart  disease,  including  adverse  pregnancy  outcomes  (ie,  preeclampsia,  gestational  diabetes,  preterm  birth,  or  small  for  gestational  age  birth),  premature  ovarian  failure  or  early  menopause,  or  comorbidities  such  as  autoimmune  disease  or  the  sequelae  of  cancer  treatments  (ie,  chest  wall  radiation,  or  trastuzumab  or  anthracycline  treatment  for  breast  cancer).  Each  of  these  may  be  considered  a  "risk-enhancer"  when  considering  future  CVD  risk.